CIK 0000899460 · Large accelerated filer
MANNKIND CORP
Sign in to watch- Ticker
- MNKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133607736
- Phone
- 818-661-5000
- Business address
- 1 CASPER STREET, DANBURY, CT, 06810
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $256,334
- in 2 filings, $256K under 10b5-1 plans
Net −$256,334. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-12 | Thomson David EVP Genl Counsel & Secretary | Shares withheld for taxes 10b5-1 | −12,364 | $4.56 | $56K | 804,606 |
| 2025-05-12 | Binder Steven B. Director | Shares withheld for taxes 10b5-1 | −87,430 | $4.56 | $399K | 1,093,196 |
| 2025-05-12 | Binder Steven B. Director | Shares withheld for taxes 10b5-1 | −6,441 | $4.56 | $29K | 1,086,755 |
| 2025-05-12 | Tross Stuart A Chief People & Workpl Officer | Shares withheld for taxes | −88,724 | $4.56 | $405K | 984,067 |
| 2025-05-12 | Tross Stuart A Chief People & Workpl Officer | Shares withheld for taxes | −8,051 | $4.56 | $37K | 976,016 |
| 2025-05-12 | Castagna Michael Chief Executive Officer | Shares withheld for taxes | −334,954 | $4.56 | $1.5M | 2,218,942 |
| 2025-05-12 | Castagna Michael Chief Executive Officer | Shares withheld for taxes | −34,894 | $4.56 | $159K | 2,184,048 |
| 2025-05-10 | Thomson David EVP Genl Counsel & Secretary | Grant or award 10b5-1 | +105,600 | 935,443 | ||
| 2025-05-10 | Binder Steven B. Director | Grant or award 10b5-1 | +105,600 | 1,180,626 | ||
| 2025-05-10 | Tross Stuart A Chief People & Workpl Officer | Grant or award | +105,600 | 1,072,791 | ||
| 2025-05-10 | Castagna Michael Chief Executive Officer | Grant or award | +298,560 | 2,553,896 | ||
| 2025-04-04 | Castagna Michael Chief Executive Officer | Other disposition | −39,500 | 2,255,336 | ||
| 2025-03-27 | Sabella Lauren M EVP Operations | Shares withheld for taxes | −16,407 | $5.10 | $84K | 357,849 |
| 2025-02-12 | Marasco Dominic Pres, Endocrine Business Unit | Grant or award | +252,000 | 252,000 | ||
| 2024-11-22 | Binder Steven B. Director | Option exercise 10b5-1 | +67,536 | $1.47 | $99K | 1,142,562 |
| 2024-11-22 | Binder Steven B. Director | Sale 10b5-1 | −67,536 | $6.89 | $465K | 1,075,026 |
| 2024-11-22 | Binder Steven B. Director | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −22,512 | 0 | ||
| 2024-11-22 | Binder Steven B. Director | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −22,512 | 0 | ||
| 2024-11-22 | Binder Steven B. Director | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −22,512 | 0 | ||
| 2024-11-18 | Binder Steven B. Director | Grant or award · Deferred Restricted Stock Unit 10b5-1 | +17,575 | 17,575 |
Page 9 of 11 · 210 trades